Literature DB >> 24691746

Prevalence and risk of viral infection in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis.

Xiaodong Wu1, Du Chen, Xiaoling Gu, Xin Su, Yong Song, Yi Shi.   

Abstract

Exacerbations of chronic obstructive pulmonary disease (COPD) lead to substantial morbidity and mortality. Viral infections could be an important cause of acute exacerbations of COPD (AECOPD) and only a few studies report the prevalence of respiratory viruses on this disease. We aimed to update the review on the prevalence of respiratory viral infection in patients with AECOPD with a meta-analysis. We reviewed the prevalence of respiratory viruses on this disease by searching PubMed systematically to identify primary studies published from Jan 1990 to March 2012. Studies met with seven criteria were extracted for meta-analysis. A total of 17 studies were eligible for the meta-analysis. Weighted overall prevalence of respiratory viruses in patients with AECOPD was 39.3% (95% CI 36.9-41.6) with a high degree of a heterogeneity (I (2) > 75%). In contrast, the rate in stable COPD patients from four studies was 13.6% (95% CI 9.0-18.2) without any apparent heterogeneity. Pooled risk ratio for respiratory viral infection was 4.1 (95% CI 2.0-8.5) for AECOPD as compared with stable COPD. Rhinovirus was the most common virus and with a weighted prevalence of 14.8% (95% CI 13.3-16.5). Respiratory viruses probably are important etiological agents in patients with AECOPD as compared with the stable COPD patients. This result would help to provide better strategies for management of AECOPD and health-care planning.

Entities:  

Mesh:

Year:  2014        PMID: 24691746     DOI: 10.1007/s11033-014-3345-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  34 in total

Review 1.  Immunologic aspects of chronic obstructive pulmonary disease.

Authors:  Manuel G Cosio; Marina Saetta; Alvar Agusti
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

Review 2.  Infection in the pathogenesis and course of chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi; Timothy F Murphy
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245

3.  Two-sided confidence intervals for the single proportion: comparison of seven methods.

Authors:  R G Newcombe
Journal:  Stat Med       Date:  1998-04-30       Impact factor: 2.373

4.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.

Authors:  T A Seemungal; G C Donaldson; A Bhowmik; D J Jeffries; J A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

5.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

6.  Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Carlos A Camargo; Adit A Ginde; Sunday Clark; Charles P Cartwright; Ann R Falsey; Dennis E Niewoehner
Journal:  Intern Emerg Med       Date:  2008-09-30       Impact factor: 3.397

7.  Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease.

Authors:  Manisha Singh; Seung-Hyo Lee; Paul Porter; Chuang Xu; Ayako Ohno; Robert L Atmar; Stephen B Greenberg; Venkata Bandi; Jim Gern; Svetlana Amineva; Alex Aminev; Tim Skern; Pamela Smithwick; Sarah Perusich; Nadia Barrow; Luz Roberts; David B Corry; Farrah Kheradmand
Journal:  J Allergy Clin Immunol       Date:  2010-06       Impact factor: 10.793

8.  Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.

Authors:  Alberto Papi; Cinzia Maria Bellettato; Fausto Braccioni; Micaela Romagnoli; Paolo Casolari; Gaetano Caramori; Leonardo M Fabbri; Sebastian L Johnston
Journal:  Am J Respir Crit Care Med       Date:  2006-02-16       Impact factor: 21.405

9.  Respiratory viral infections in patients with chronic, obstructive pulmonary disease.

Authors:  J David Beckham; Ana Cadena; Jiejian Lin; Pedro A Piedra; W Paul Glezen; Stephen B Greenberg; Robert L Atmar
Journal:  J Infect       Date:  2005-05       Impact factor: 6.072

Review 10.  COPD exacerbations: defining their cause and prevention.

Authors:  Jadwiga A Wedzicha; Terence A R Seemungal
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

View more
  11 in total

1.  The Anti-inflammatory Effect of Alpha-1 Antitrypsin in Rhinovirus-infected Human Airway Epithelial Cells.

Authors:  Di Jiang; Reena Berman; Qun Wu; Connor Stevenson; Hong Wei Chu
Journal:  J Clin Cell Immunol       Date:  2016-12-05

Review 2.  Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation.

Authors:  Bethany B Moore; Thomas A Moore
Journal:  Ann Am Thorac Soc       Date:  2015-11

3.  Sputum Bacterial and Fungal Dynamics during Exacerbations of Severe COPD.

Authors:  Jin Su; Hai-yue Liu; Xi-lan Tan; Yong Ji; Yun-xia Jiang; M Prabhakar; Zu-hua Rong; Hong-wei Zhou; Guo-xia Zhang
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

4.  Respiratory viruses in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Parvaiz A Koul; Hyder Mir; Shabir Akram; Varsha Potdar; Mandeep S Chadha
Journal:  Lung India       Date:  2017 Jan-Feb

Review 5.  The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic review.

Authors:  Ann D Colosia; Jin Yang; Eric Hillson; Josephine Mauskopf; Catherine Copley-Merriman; Vivek Shinde; Jeffrey Stoddard
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

Review 6.  Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Xianghui Zhou; Qingling Li; Xincan Zhou
Journal:  Cell Biochem Biophys       Date:  2015-11       Impact factor: 2.194

7.  Molecular epidemiology and clinical impact of rhinovirus infections in adults during three epidemic seasons in 11 European countries (2007-2010).

Authors:  Kalina T Zlateva; Anneloes L van Rijn; Peter Simmonds; Frank E J Coenjaerts; Anton M van Loon; Theo J M Verheij; Jutte J C de Vries; Paul Little; Christopher C Butler; Erik W van Zwet; Herman Goossens; Margareta Ieven; Eric C J Claas
Journal:  Thorax       Date:  2020-08-20       Impact factor: 9.139

8.  Study of respiratory viruses and their coinfection with bacterial and fungal pathogens in acute exacerbation of chronic obstructive pulmonary diseases.

Authors:  Rahat Jahan; Baijayantimala Mishra; Bijayini Behera; Prasanta Raghab Mohapatra; Ashok Kumar Praharaj
Journal:  Lung India       Date:  2021 Jan-Feb

9.  Prevalence and clinical implications of respiratory viruses in stable chronic obstructive pulmonary disease (COPD) and exacerbations: a systematic review and meta-analysis protocol.

Authors:  Anastasia M Kefala; Rebecca Fortescue; Gioulinta S Alimani; Prodromos Kanavidis; Melissa Jane McDonnell; Emmanouil Magiorkinis; Spyridon Megremis; Dimitrios Paraskevis; Chrysa Voyiatzaki; Georgios A Mathioudakis; Effie Papageorgiou; Nikolaos G Papadopoulos; Jørgen Vestbo; Apostolos Beloukas; Alexander G Mathioudakis
Journal:  BMJ Open       Date:  2020-04-07       Impact factor: 2.692

10.  Bacterial and viral infections and related inflammatory responses in chronic obstructive pulmonary disease.

Authors:  Silvestro Ennio D'Anna; Mauro Maniscalco; Francesco Cappello; Mauro Carone; Andrea Motta; Bruno Balbi; Fabio L M Ricciardolo; Gaetano Caramori; Antonino Di Stefano
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.